CervoMed Appoints New Chair and Presents at Conference 67
Company Announcements

CervoMed Appoints New Chair and Presents at Conference 67

CervoMed (CRVO) has released an update.

Dr. Joshua S. Boger has been elected as a director and the Chair of the Board of a notable company, an update which was released in a recent press announcement. Additionally, the company’s senior management team is set to present at the prestigious Emerging Growth Conference 67, showcasing their strategic vision and growth prospects to potential investors and industry stakeholders.

For further insights into CRVO stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TheFlyCervoMed to present on neflamapimod as DLB treatment at CTAD
TheFlyCervoMed initiated with a Buy at Chardan
TipRanks Auto-Generated NewsdeskCervoMed Updates Investors on Business and Clinical Progress
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App